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Recently we have described (1) an IgM antibody that has the unique property
of specific self binding. The 11 E7-1 hybridoma was isolated by fusion with a
nu/nu BALE/c mouse immunized with TEPC 15 myeloma protein (T15) . The
mAb 11 E7-1 binds to PC, to insolubilized T15, and to 11E7-1 itself. Thebinding
is specifically inhibited by free PC and PC analogs . Thus, this antibody has a
dual specificity of binding to PC and of expressing an idiotope for PC inhibitable
self binding . Because of the simultaneous expression ofcomplementary paratope
and idiotope it has been termed "autobody" (2-4) .
The specificity of self binding appears to be extremely stringent, since as little
as 10-7 M PC inhibits 50% self binding in ELISA . Furthermore, the strength of
inhibition by PC, glycerophosphorylcholine (GPC),' and choline follows the same
pattern as the PC fine specificity ofT15 binding to PC (5) . This seemsto suggest
that the PC binding site (paratope) of 11E7-1 is similar to the paratope of the
T15 prototype, and also that the PC site is directly involved in the self binding.
A rational interpretation of these properties of 11 E7-1 implies that this antibody
expresses a paratope for the antigen and its complementary internal image
idiotope (6) .
11 E7-1 also expresses the T15 idiotype because it reacts with an anti-T 15
mAb, F6-3, that reacts withT15 idiotype-positive antibodies ofdifferent isotypes
(7) . This finding led us to speculate that 11E7-1 may be part of a self-regulating
idiotypic cellular loop controlling the normal anti-PC response or may cause
complex deposition on pathogenic targets . Regardless of the biological meaning
of a complementary self-binding antibody, this unique dual expression of para-
tope and idiotope has important ramifications for the network hypothesis .
In this update on our studies of the 11 E7-1 autobody, we addressed the
question of the structural origin of the autobody properties. The PC-specific self
binding could be caused by a somatic mutation of the T15 prototype structure
in which the PC paratope remained intact and an internal image idiotope has
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been created. Sequence analysis of the variable L and H chain regions of 11 E7-
1 would indicate the presence of structural changes in the germline T 15.
Alternatively, the self-binding property may be inherent in the T15 prototype
structure and its expression may be subject to enhancement by Ig subunit-
mediated effects. While under normal experimental conditions of working with
T 15'' antibodies in solution the self-binding activity is not well expressed, it may
be seen after stabilization of the T 15 structure absorbed to surfaces. In this case,
the valency of interactions between surface-bound T15 and T15 in solution
could be an important factor to promote self binding.
Our data reported here clearly demonstrate that the variable region sequence
of L and H chains of 11 E7-1 is identical to the germline sequence of T 15, and
that the self-binding property of 11 E7-1 is shared by other T 15 prototype
antibodies. Therefore, self binding is an inherent characteristic of the T15
prototype. We also show that the self-binding ability is a function of the valency
of the T 15 structure.
Materials and Methods
Myeloma and Hybridoma Proteins.
￿
Myeloma cell line T15 was obtained from Litton
Bionetics, Kensington, MD, and the antibody was purified from ascitic fluid by a PC-
Sepharose column. The anti-TNP myeloma antibody MOPC 315 (M315) was the kind
gift of Mr. G. Radzimski, Roswell Park Memorial Institute, Buffalo, NY. mAb 11E7-1
was prepared in our laboratory and purified from ascites by affinity chromatography on
T15-Sepharose column or PC-Sepharose column (1). mAb 4F1 was prepared in our
laboratory and purified from ascites by affinity chromatography on M 167-Sepharose
column (8). HPCG14 hybridoma protein was a gift from Dr. P. Gearhart, Johns Hopkins
University, Baltimore, MD (9). The antiphthalate hybridoma antibody 3A4 was a gift
from Dr. R. B. Bankert, Roswell Park Memorial Institute. The anti-human T cell leukemia
mAb SN2 was a gift from Dr. B. K. Seon, Roswell Park Memorial Institute (10). mAbs
ION 3/2 and LN 12/4 were gifts from Dr. C. Bona, Mount Sinai Medical School, New
York. mAb F6-3 was prepared in our laboratory (7) and was purified on a T 15-Sepharose
column.
F(ab')2 Fragmentation and H and L Chain Separation of T15.
￿
The F(ab')2 fragment of
the T15 antibody was prepared by pepsin digestion according to Lamoyi and Nisonoff
(11). After digestion, various digestion fractions were separated by passing through a
Sephacryl S-200 column; the peak fractions following the undigested Ig peak were pooled
and found to be F(ab')2 fragments. Isolated T15 H and L chains were prepared by the
method of Berek et al. (12). 10 mg of monomeric T15 was dialyzed overnight against 6
M urea in the presence of 1 N acetic acid. Chains were separated on a Sephacryl S-200
column equilibrated in dialysis buffer.
Preparation of Monomeric, Dimeric T15, and Pentameric 11E7-1.
￿
Dimeric T15 and a
pentameric 11 E7-1 were purified directly from ascites by a PC-Sepharose column. To
obtain a monomeric T15, ascites was reduced and alkylated before purification using 5
mM DTT and 0.01 M iodoacetamide at the final concentration. The purities and
molecular weights of the antibodies were confirmed by HPLC analysis. 10 j1 of each
antibody was run through a Superose 6HR 10/30 column. A buffer containing 0.05 M
phosphate and 0.15 M NaCl at pH 7.0 was used as the eluent at a flow rate of 0.6 ml/min.
The column effuent was monitored at 254 nm.
ELISA.
￿
A microtiter plate was coated for 18 h with 0.1 ml/well of T15 (2,ug/ml) in
PBS, washed three times, and incubated for 1 h with 1 % BSA in PBS. After washing
three times, 25 ng of enzyme-coupled 11 E7-1 in 1% BSA and 0.05% Tween 20/borate-
buffered saline (BBS) was added in the absence or presence ofinhibitors. Enzyme-coupled
goat anti-mouse IgM was used for detecting antibody binding to the microtiter plate.1334
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After washing three times, color was developed with substrate and the OD405 was
measured.
Radioimmunoassay.
￿
Microtiter plates were coated for 18 h with 0.1 ml of purified
antibodies (5 mg/ml) or PC>-BSA (2,ag/ml) in PBS, washed three times, and incubated for
1 hwith 1 % BSA in PBS. After washing, '25I-labeled antibodies were addedin theabsence
or presence of inhibitors. After 18 h of incubation, the wells were extensively washed and
the bound radioactivity of individual wells was determined in a gamma counter (Packard
Instrument Co., Inc., Downers Grove, IL). For further details, see legends for figures and
tables.
RNA Preparation.
￿
Total cellular RNA was prepared by modification of the guanidin-
ium monothiocyanate method (13). Poly(A)+ RNA was isolated on oligo(dT)-cellulose
columns.
Synthesis and Labeling of Oligonucleotide Primer.
￿
The oligonucleotide primer from the
5' end ofthe mouse K chain constant region wasobtained as a gift from Dr. P. W. Tucker,
University of Texas Health Science Center, Dallas, TX. Other oligonucleotide primers
were synthesized with a DNA synthesizer (No. 380A; Applied Biosystems, Inc., Foster
City, CA) in our laboratory. Theprimers were labeled at the 5' end with y-["P]ATP and
T4 polynucleotide kinase (International Biotechnologies, Inc., New Haven, CT) (14).
Synthesis and Sequencing of cDNA.
￿
cDNA was synthesized with Avian myeloblastosis
virus reverse transcriptase (Life Science Inc., St. Petersburg, FL) as described by Sood et
al. (15).ThecDNA waspurified by electrophoresisthrough 40 cm of 6% polyacrylamide/7
M urea preparative gels. Sequencing ofcDNA wasperformed by thechemical degradation
method (14).
Protein Sequence Analysis.
￿
The L chain NH2-terminal sequence was determined on a
protein sequencer (No. 470 A; Applied Biosystems, Inc.) in conjunction with an on line
No. 120 PTH analyzer (Applied Biosystems, Inc.).
Results
The Variable Region is Involved in Self Binding of 11E7-1 .
￿
A previous report
(1, 2) suggested that the 11 E7-1 antibody (IgMK) has two functional sites; one is
a paratope for binding to the PC antigen and the other is an idiotope that is
complementary to its own paratope. Through this paratope and idiotope, 11 E7-
1 exhibit the antiidiotypic and self-binding activities. To investigate whether the
variable region is involved in the self binding of 11 E7-1, the F(ab')2 fragment of
T15 was used as an inhibitor in the binding of I 1E7-1 to T15. Since we will
demonstrate later that T15 has the same variable region sequence and self-
binding activity as 11 E7-1, the F(ab')2 fragment of T15 represents the variable
region of 11 E7-1 . Plates were coated with monomeric T15 and incubated with
enzyme-labeled I 1E7-1 in the presence of inhibitors. As seen in Fig. 1, intact 7s
T 15 was the best inhibitor; the F(ab')2 of T15 was also an effective inhibitor,
while the free L chain or H chain could not inhibit the binding. These results
indicate that the variable region of T15 is the target for binding by 11 E7-1 .
Next, the hapten specificity of theself bindingwasanalyzed. Plates were coated
with 11 E7-1 and incubated with 12'1-labeled IIE7-1 in the presence of various
haptens. As seen in Table I, only PC was able to inhibit the self binding. This
confirms our previous findings (1). Since 4-hydroxy-3-nitro-phenyl (NP), DNP,
and al-6 dextran do not inhibit the self binding, self binding is highly specific,
involving the binding site (paratope) for PC . Although these data do not exclude
the possibility that 11 E7-1 binds to T15 via the Fc region, we can eliminate this
possibility because of the following observations (see also Table II): (a) I lE7-1
or T15 does not bind to other IgM antibodies, and (b) antibodies of differentc
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TABLE I
Inhibition ofSelfBindingof IIE7-1 by Different Haptens
FIGURE 1 . Inhibition of 11E7-1
binding to T15 by F(ab')s of T15.
The microtiter plate was coated for
18 h at 4°C with 2 wg/ml of T15,
then washed andblocked by 1 % BSA
in PBS. After washing, 25 ng of en-
zyme-labeled I 1 E7-1 was added in
the presence or absence of inhibitors.
The percent inhibition were calcu-
lated.
Microtiter plates were coated for 18 hat 4°Cwith 100jul/well of I I E7-
1 (5 Ag/ml) in PBS, washed three times, and incubated for 1 h with 1 %
BSA in PBS. After washing, ''-I-11 E7-1 (45,000 cpm) was incubated in
the absence ofinhibitor or in the presence of inhibitors (10' M).
* Binding is expressed as mean ± SD of cpm (n = 3).
$ [(4-Hydroxy-3-nitro-phenyl)acetyl]caproate was used as the NP hapten.
9 Dinitrophenyl glycine was used as the DNPhapten.
Nigerose wasused as the dextran hapten.
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isotype but of identical variable region, such as 11E7-1, have the self-binding
and antiidiotypeactivities. From theseobservations, we conclude thatthe binding
target and binding site on 11E7-1 are both in the variable region. In otherwords,
the self binding involves a complementary idiotope and paratope in the variable
region. The failure of H or L chain to inhibit the selfbinding indicates that the
complementary self-binding idiotope is of combinatorial nature requiring inter-
action ofboth chains.
The Variable Regions of IIE7-1 and S107 are Identical.
￿
The results regarding
the self-binding properties of 11E7-1 raise the interesting question ofthe molec-
ular basis of self binding. Since 11E7-1 expresses the T15 idiotype as shown
previously (1), the question must be addressed whether 11E7-1 has the sequence
ofthe T15 prototype or a variant of T15.
The H and L chain nucleotide sequences of 11E7-1 were determined by
primer extension sequencing. The complete nucleotide sequence of the variable
region ofthe 11E7-1 H chain and a comparison with the Hchain ofthe myeloma
Inhibitors (10' M) Binding of '2s-1-11E7-1 Inhibition
cpm*
Nil 20,936 t 280 0
PC 135 ± 6 99.8
NP* 21,015 t 493 -0.4
DNPÎ 20,801 ± 378 0.6
Dextranl 20,932 ± 382 01336
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TABLE II
Specificity ofSelfBinding ofDifferentPolymeric Forms ofAntibodies
Binding of "'I-antibody-
Plates coated with:
￿
Specificity
￿
Isotype
￿
T15monomer
￿
T15 dimer
￿
I IE7-1 (pentamer)
-PC +PC -PC +PC -PC +PC
Microtiter plates were coated for 18 h at 4°C with 5 pg/ml of different antibodies, washed, and blocked by 1% BSAsolution. After washing
three times, 45,000 cpm of each "'l-antibody in 1%BSA, and 0.05% Tween 20/BBS was added in the absence of PC or in the presence of
PC (10-s M).
* Binding is expressedas mean ±SD ofcpm (n = 3).
S107 (16, 17) are shown in Fig. 2. The nucleotide sequence of the I 1E7-1 H
chain is identical to the sequence of S107. A similar comparison of the 11 E7-1
L chain with S107 (18) is shown in Fig. 3. Because the DNA sequence for the
leader segment on the L chain differed from the known 5107 sequence (data
not shown), we confirmed the translated protein sequence for the secreted chain
by N142-terminal sequence determination. The determined protein sequence
agreed with the sequence predicted from the nucleotide sequence (see Fig. 3).
Although three nucleotide substitutions were observed in complementarity de-
termining region 2 (CDR2), the translated sequence is identical to the S107
sequence.
Self Binding Is Modulated by Ig Valency.
￿
Because of the apparent identity of
the variable region sequence of T15 and 11 E7-1, the possibility must be consid-
ered that T15 also exhibits self-binding activity. To test for T15 self binding,
1251-labeled T15 monomer was added to plates coated with apanel of antibodies.
The binding of monomeric T15 to T15 prototypes and a variant (HPCG14) is
very low but specific, since it can be inhibited by PC (see Table II). This
observation prompted us to compare self-binding activities among various poly-
meric forms of T15 prototype.
Before using various polymeric and monomeric forms of the T15 prototype
antibody, the purity of the preparations must be established. Monomeric T15,
dimeric T15, and intact pentameric 11 E7-1 were tested on HPLC using a
Superose 6HR column. Each antibody preparation yields a single symmetrical
peak eluting at the volumes corresponding to monomeric, dimeric, and penta-
meric Igs (data not shown). These various polymeric forms were tested for their
ability to bind to PC. It can be expected that the polymeric forms may be more
efficient in binding to insolubilized PC-BSA than the monomeric antibody. As
seen in Table III, the pentamer 11 E7-1 is about fivefold and the dimer about
fourfold more efficient in PC binding than the monomer T15. This difference
is not due to the affinity, because the variable regions of T15 and I IE7-1 are
T15 monomer
T15 dimer
M315
1IE7-1 (pentamer)
4FII
PC
PC
TNP
PC
M167
a, K
a, R
a, T
p, I(
K
567 ±7
536 ± 17
143 ±5
815 ±52
134±6
129 ±
131 ±
148 ±
152 ±
138±16
16
5
14
14
9,565 ±
9,367 ±
171 ±
12,679 ±
143±25
248
266
15
567
117 ± 18
138 ± 7
138 ± 23
143 ± 12
115±5
25,151 ±943
24,440 ±481
159 ± 14
22,486 ± 1,025
188±16
124
112
128
156
±21
± 10
±27
± 13
146±14
3A4 Phthalate te, K 142 ±8 143 ±21 156 ±3 134 ± 14 171 ± 10 166 ±6
IONS/2 Unknown A' . 116 ± 15 119 ±8 133 ±14 151 ± 13 172 :t 4 155 ±9
NL12/4 Unknown k, K 122 ±9 107 ± 16 127 ± 6 128 ± 26 151 ± 24 143 ±9
HPCG14 PC y,, 1 426 ±22 143 ±8 6,567 ± 191 153 ± 20 6,815 ±291 137 ± 9
SN-2 Human T y,, K 152 ± 12 142 ± 14 172 ±5 134 ± 15 178 ± 11 160 ±24
leukemia
F6.3 T15 71, K 20,753 ±642 20,568 ±781 31,541 ± 568 33,877 ± 208 40,900 ± 196 41,648 ±253KANG ET AL.
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FIGURE 2.
￿
Alignment of nucleotide and deduced amino acid sequences (one-letter code) of
the variable regions of 11 E7-1 and S107 H chains. A short segment of the constant region
containing the first oligonucleotide primer sequence is also shown. The sequences underlined
are complementary sequences of the second oligonucleotide primer that was used for sequenc-
ing. Nucleotide and amino acids identical to the 11 E7-1 are indicated by dashes.
identical. These avidity differences among various polymeric forms of T15
prototype will be compared with differences of self binding.
The two polymeric forms ofthe T15 prototype and its monomer were tested
in the self-binding assay. Plates were coated with a panel ofantibodies including
prototypes and a variant of T15 and irrelevant antibodies. "'I-labeled T15
monomer, dimer, and intact 11E7-1 were allowed to bind in the presence or
absence of 10-s M PC. The data are shown in Table 11. To consider differences
in labeling efficiencies, he data of Table II and III were recalculated and
expressed as number ofbound molecules in Fig. 4. The binding of monomeric
T15 is very low, as shown before. Self binding of T15 dimer is about 20-fold
higher than with the monomer. The binding of labeled pentameric I IE7-1 to
T15 monomer, dimer, and to 11E7-1 itself is about 50-fold more than that of
labeled monomeric T15. It was interesting to observe that the binding of various
polymeric forms of the T15 prototype to a T15 variant (HPCG14) is less than
the binding to T15 prototypes. No specific binding to antibodies of different
specificities was observed. The expression of the T15 idiotype on all labeled
-19 -10
M K L W L N W L F L L T L L N
11 E7-1 ATG AAG TTG TOG TTA AAC TOO TTG TTT CTT TTA ACA CTT TTA CAT
5107
.1 1 10
G 1 O C E V K L V E S G G G L V O
GOT ATC CAG TGT GAG GTG AAG CTG GTG GAA TCT GGA GOA GGC TTO GTA CAG
20 30
P G G S L R L S C A T S G F T F S
CCT
---
GGG
---
GGT
---
TCT
---
CTG
---
AGA
---
CTC
---
TCC
---
TOT
---
GCA
---
ACT
---
TCT
---
GGG
---
TTC
---
ACC
---
TTC
---
AGT
---
40
D E Y M E W V R O P P G K R L E W
GAT TTC TAC ATG GAG TOG OTC CGC GAC CCT CCA GGG AAG AGA CTG GAG TOG
50 90
I A A S R N K A N D V T T E Y S A
ATT
---
GCT
---
GCA
---
AGT
---
AGA
---
AAC
---
AAA
---
OCT
---
AAT
---
GAT
---
TAT
---
ACA
---
ACA
---
GAG
---
TAC
---
AGT
---
GCA
---
70
S V K G R F I V S R D T S O S I L
TCT
---
GTG
---
AAG
---
GOT
---
COG
---
TTC
---
ATC
---
OTC
---
TCC
---
AGA
---
GAC
---
ACT
---
TCC
---
CAA
---
AGC
---
ATC
---
CTC
---
SO 90
Y L O M N A L R A E D T A I Y Y C
TAC
---
CTT
---
CAG
---
ATG
---
AAT
---
GCC
---
CTG
---
AGA
---
OCT
---
GAG
---
GAC
---
ACT
---
GCC
---
ATT
---
TAT
---
TAC
---
TGT
---
100
A R D Y T G S S Y W Y F D V W G A
GCA AGA GAT TAC TAC GOT AGT AGC TAC TOG TAC TTC GAT GTC TOG GGC GCA
110 ? Constant region
G T T V T V S S E S O S F P N V F
GGG ACC ACG GTC ACC GTC TCC TCA GAG AGT CAG TCC TTC CCA AAT GTC TTC
First
P L V
CCC CTG GTC TC
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￿
Fint Primmer
FIGURE 3.
￿
Alignment of nucleotide and deduced amino acid sequences (one-letter code) of
the variable regions of 11 E7-1 and 5107 L chains. Determined protein sequence is indicated
by a specific line (_). Otherdetailsare the same as in Fig. 2.
Specificity ofDifferent Polymeric Forms ofAntibodiesfor PC-BSA
Binding of '25I-antibody*
TABLE III
Microtiter plates were coated for 18 hat 4°C with 2 wg/ml of PC7-BSA, then washed
and blockedby I% BSA solution. After washingthree times, 45,000 or 22,500 cpm
of each 121I-antibody in 1% BSA and0.05% Tween/BBS was added in the absence of
PC or in the presence ofPC (I0-' M).
* Bindingis expressed as mean ± SD of cpm (n = 3).
probes is demonstrated by strong binding to the anti-T15 mAb, F6-3. It is
important to note that the differences between monomeric and polymeric T15
prototype antibodies in binding to F6-3 are only twofold.
1
D I V M T O S
11E7-1
5107
GAC
___
ATT
_.._
GTG
___
ATG
___
ACT CAO TCT
___ __.. ---
-2, I V M T O S
10 20
P T F L A V T A S K K V T 1 S C T
CCA ACT TTC CTT GCT GTG ACA GCA AGT AAG AAG GTC ACC ATT AGT TGC ACG
30
A S E S L Y S S K H K V H Y L A w
GCC ACT GAG AGC CTT TAT TCA AGC AAA CAC AAG GTG CAC TAC TTG GCT TGG
__X TC_
40 50
Y O K K P E O S P K L L I Y G A S
TAC CAG AAG AAG CCA GAG CAA TCT CCT AAA CTG CTG ATA TAC GOG OCA TOC
60
N R Y 1 G V P D R F T G S G S G T
AAC CGA TAC ATT GOG OTC CCT GAT CGC TTC ACA GGC AGT GGA TCT GOG ACA
70 so
D F T L T I S S V O V E D L T H Y
GAT TTC ACT CTG ACC ATC AGC AGT GTA CAG OTT GAA GAC CTC ACA CAT TAT
110 100
Y C A O F V S Y P L T F G A G T K
TAC TGT GCA CAG TTT TAC AGC TAT CCT CTC ACG TTC GGT OCT GOG ACC AAG
100 ) Constant region
L E L K R A D A A P T V S I F P
CTG GAG CTO AAA COG OCT GAT OCT GCA CCA ACT GTA TCC ATC TTC CCA CC
Radiolabeled antibody Addedamount
without PC
45,000
cpm
with PC
22,500
Without PC
cpm
With PC
T15 monomer 7,423 .t 339 128 t 6 3,875 t 173 127 ± 7
T15 dimer 27,422 ± 272 166 t 18 13,372 ± 142 133 t 3
11 E7-1 pensamer 39,042 ± 298 221 ± 18 19,024 t 322 136 t 10KANG ET AL .
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FIGURE 4 .
￿
Efficiency of self binding by polymeric and
monomeric antibodies. The assays were the same as in
Tables 11 and 111 . The counts per minute of added and
bound antibody were converted to number of molecules .
The number of added antibodies was standardized to
1,000 molecules .
From these results (Table II and Fig . 4), one can see that the differences in
antigen binding among monomerT15, dimer T15, and pentamer 11E7-1 are
less pronounced than the differences in self binding . 16% of the monomer T15
binds to PC, while only 1-2% self binding is observed with the monomer . The
PC binding of the pentameric 11 E7-1 reaches 86% while the self binding is
-50% . It is interesting to note that the increase in the number of self-binding
antibody molecules with an increase in the polymeric state is more dramatic than
in the number of antigen-binding antibody molecules . These differences need to
be considered in an attempt to describe the structural basis and biological
significance of self-binding antibodies.
Discussion
The data on the specificity and structure of autobody antibodies demonstrate
three major points : (a) the T15 IgA antibody that has the germline sequence of
the T15 V,, and V,, prototype, has self-binding activity similar to the IgM I IE7-
1 described previously (1); (b) the self binding is greatly influenced by the
polymeric state of the T15 prototype structure and is therefore dependent on
the valency of the antibody ; and (c) the translated protein structure of the IgM
11 E7-1 and the IgA S107 are identical to Ig variable regions .
The strong valency dependence of the self-binding property is intriguing for
the concept of network regulation because self binding is most pronounced with
the IgM isotype that represents the primary response class and also represents
the membrane-bound receptor on B cells . The differences in self binding are
much greater between different isotypes than the avidity differences in antigen
binding . At the stoichiometric level, 50 times more molecules of IgM are self
binding than of IgA monomer antibodies . The possibility that these avidity
differences are directly caused by the constant region of the IgM are excluded1340
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by showing similar differences with monomeric and dimeric IgA T15 in self
binding. Because attempts to producepure soluble monomeric IgM 11E7-1 were
unsuccessful, the self binding of 11E7-1 monomer and pentamer could not be
compared. Modulation ofthe expression ofidiotopes by constant region domains
have been observed (19-21); however, these differences are not related to the
polymeric state of the molecule. Thus, we are inclined to assign the self-binding
site to the paratope site for PC or close to this site, mainly because PC inhibits
selfbinding and the binding is affected by valency.
The finding that the protein sequences of 11E7-1 and T15 are identical was
at first surprising. It forced us to reexamine whether the T15 IgA antibody also
has self-binding properties. It also directed our attention to the question of
valency in self binding. Monomeric T15 has very low self-binding activity, as
only 1-2% of T15 antibodies may bind to insolubilized T15 or 11E7-1 under
the conditions of our assay. This low self binding, although very specific, may
have been taken for background binding and therefore neglected in previous
work with T15 antibodies, because typically these antibodies are purified on
affinity chromatography after mild reduction and alkylation (5). The sequence
data demonstrate that the self-binding site is an inherent property of the T15
germline antibody structure.
In terms ofa structural interpretation ofthe T15 antibody as an autobody (1),
a simultaneous expression ofa paratope and an internal PC image in the germline
antibody must be assumed. Accepting that the self-binding structure is in part
generated by an internal PC image idiotope, it is interesting to compare this
idiotope with another T15-associated idiotope detected by the anti-T 15 mAb
F6-3 (7). The expression of the F6-3 idiotope is only marginally affected by the
valency of the antibody. Thus, the self-binding idiotope may have a unique
structure and/or function within putative network regulation.
The biological significance of a self-binding autobody expressing complemen-
tary paratopes and idiotopes is an interesting subject for speculation. As pointed
out previously (1), the 11 E7-1 may represent a closed circuit feedback loop in
the network. The additional evidence on the importance ofthe valency for the
self-binding property, provided in this report, adds some more specific points on
this scenario. For example, it could be that in early ontogeny, emerging B cells
committed to the T15 idiotype expression and stimulated by environmental PC
antigens bind secreted IgM free of PC antigen. This surface-bound IgM, in turn,
would be internalized and could provide a stimulatory signal, thereby initiating
clonal proliferation. The same mechanism also could augment presentation of
internalized antigen to Th cells. Together, both or either process could produce
a clonally dominant expression of the T15 clone seen in some strains of mice
(22, 23). Experiments to evaluate this hypothesis are in progress.
With respect to the structural basis of the self-binding site, it is important to
remember that the self-binding site is poorly evident in monomeric T15' anti-
PC antibodies, but readily detected with increase of Ig polymerization. Because
ofthis dependence on avidity of the overall Ig complex it resembles similar but
lesspronounced effects on the strength ofthe classical binding site. It is therefore
tempting to assign the self-binding site to the antigen-binding site. An argument
in favor of this,is that both sites need the interaction of H and L chain variableKANG ET AL.
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domains. However, the increased self binding in polymeric forms is not simply
additive but highly synergistic. This effect is reminiscent of classical allosteric
mechanisms in biologically active molecules that operate through subunit inter-
actions, like hemoglobin or allosteric enzymes. The inhibition ofthe self-binding
effect by free PC may thus be interpreted as an allosteric effect on the self-
binding site. Thus, an alternative model emerges in which two different sites or
subsites within the same region have a reciprocal allosteric effector connection,
one PC-binding site and an independent self-binding site.
The discovery of an inherent self-binding potential in the germline structure
ofan idiotype dominant antibody that reacts with environmental and pathogenic
organisms raises several interesting questions. First, how can the dual properties
of the T15 prototype as antigen binding and antigen-sensitive self binding be
interpreted in terms ofa three-dimensional model. Since a related three-dimen-
sional model for T15 Fab exists from the crystallographic data on McPC 603
(24), it should be helpful to construct, by computer modeling, a predicted
structure for the Fab fragment of T15. Such a model may give clues as to how
self binding by T15 may be achieved and which parts of the variable domains
are interacting.
Alternatively, the residues involved in selfbindingcould be deduced by testing
T15 variants for loss ofself binding. Ifthe primary structure of such variants is
known, comparison with other variants exhibiting self binding should identify
the critical residue(s) and sequence positions. These studies could then be
extended by inducing specific mutations into the L and H chain genes and
determining the binding and idiotypic properties oftheir expressed antibodies.
The other interesting aspect of the self-binding T15 prototype is its possible
biological function in the idiotype network. T15 is the dominant idiotype in the
anti-PC response in BALB/c and appears to be under idiotypic regulation (25-
27). The self-binding idiotype could be regulated by itself in a feedback-type
loop in which antigen would have a decisive control function, since it inhibits
self binding. In another interesting model, self binding of secreted polymeric
T15' IgM to the cellular T15' Ig receptor for PC could mimic antigen binding
and induce Ig internalization andpresentation ofa PC-mimicking idiotype to Th
cells that recognize T15 idiotypes (28, 29). By this mechanism, the T15 clone
could be expanded to a dominant level in the absence of antigenic stimulation.
An important question is whether self-binding antibodies occur in other systems
that are characterized by clonal dominance. In any event, the description of
germline sequences encodingautobody reactivity provides an additional facet of
the network system, and experiments designed to more fully delineate the role
ofsuch determinants are currently in progress.
Summary
We have previously described (1-3) an IgM antibody that binds to PC,
expresses the T15 idiotype, and binds also to itself or T15 if insolubilized.
Because ofthe simultaneous presence ofcomplementary idiotopes and paratopes
this type ofantibody has been termed autobody. The self binding involves the
antigen-binding site because the F(ab')2 fragment of T15, PC, and no other
haptens inhibit the selfbinding. DNA sequence analysis of 11E7-1 using primer134 2
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extension cDNA sequencing showed that the variable sequences of H and L
chains of 1 I E7-1 are identical to the germline sequence of the prototype T 15
idiotype. Furthermore, monomeric and dimeric T 15 IgA were shown to bind to
insolubilized T15 and other T15' antibodies including I IE7-1 . Thus, the self-
binding activity is an inherent property of the T 15 germline sequence. The self
binding is highly dependent on the polymeric state of the binding antibody since
the IgM pentamer of 11 E7-1 is about three fold more effective than the T 15
dimer and 50 times more than the T15 monomer .
These data suggest that the self-binding activity of a germline-encoded idiotype
may play an important role in the biology of its expression, and more specifically,
may be responsible for the establishment of its dominant expression.
We thank Dr. A. Sood for help in nucleotide sequencing, and Mrs. C. Zuber and Mrs. D.
Ovak for preparation of the manuscript.
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